Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency

Thrombosis and Haemostasis

Volumn 84, Issue 2, 2000, Pages 250-257

  Peyvandi, Flora ^a   Jenkins, P Vincent ^a   Mannucci, Pier M ^d   Billio, Atto ^b   Zeinali, Sirous ^c   Perkins, Stephen J ^a   Perry, David J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b City Hospital   (Italy)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d Royal Free Campus ^*

Author keywords

Coagulation disorders; Factor VII; Molecular modelling; Mutations; Phenotypes

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; SERINE PROTEINASE; THROMBOPLASTIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; CRYSTAL STRUCTURE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MISSENSE MUTATION; MOLECULAR BIOLOGY; MOLECULAR MODEL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0033867990     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614004     Document Type: Article

References (39)

1. Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-91.
2. Osterud B, Rapaport S. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
3. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731-6.
4. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodhury RG, Hart CE, Insley M, Kisiel W, Kurachi K. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-6.
5. Bajaj SP, Rapaport SI, Brown SF. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 1981; 256: 253-9.
6. O'Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158-62.
7. Berkner K, Busby S, Davie E, Hart C, Insley M, Kisiel W, Kumar A, Murray M, O'Hara P, Woodbury R. Isolation and expression of cDNAs encoding human factor VII. Cold Spring Harb Symp Quant Biol 1986; 51: 531-41.
8. Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-7.
9. Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia 1997; 3: 242-6.
10. Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EGD. Inherited factor VII deficiency: Molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 151-60.
11. Jenkins PV, Pasi J, Perkins SJ. Molecular modelling of ligand and mutation sites of the Type A domains of human von Willebrand factor and their relevance to von Willebrand's disease. Blood 1998; 91: 2032-44.
12. Pike ACW, Brzozowski, AM, Roberts SM, Olsen OH, Persson E. Structure of human factor VIIa and its implications for the triggering of blood coagu-lation. Proc Nat Acad Sci USA 1999; 96: 8925-30.
13. Kemball-Cook G, Johnson DJD, Tuddenham EGD, Harlos K. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). J Struct Biol 1999; 127: 213-23.
14. Banner DW, D'Arcy A, Chene C, Winkler FW, Guha A, Konigsberg WH, Nemerson Y, Kirchoger D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380:41-4.
15. Ashton AW, Boehm MK, Johnson DJD, Kemball-Cook G, Perkins SJ. The solution structure of human coagulation factor VIIa in its complex with tissue factor: A study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modelling. Biochemistry 1998; 37: 8208-17.
16. Lak M, Sharifian R, Peyvandi F, Mannucci PM. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol 1998; 103: 1067-9.
17. Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM. Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb Res 1992; 68: 283-93.
18. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 1989; 5: 874-9.
19. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-9.
20. Kabsch W, Sander C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577-637.
21. Lee B, Richards FM. The interpretation of protein structures: Estimation of static accessibility. J Mol Biol 1971; 55: 379-400.
22. Sali A, Blundell TL. The definition of topological equivalence in homologous and analogous structures: A procedure involving a comparison of local properties and relationships. J Mol Biol 1990; 212: 403-28.
23. Bernardi F, Castaman G, Redaelli R, Pinotti M, Lunghi B, Rodeghiero F, Marchetti G. Topologically equivalent mutations causing dysfunctional coagulation factors VII (294 Val) and X (334Ser Pro). Hum Mol Gen 1994; 3: 1175-7.
24. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, et al. Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994; 86: 610-8.
25. Marchetti G, Patracchini P, Gemmati D, DeRosa V, Pinotti M, Rodorigo G, Casonato A, Girolami A, Bernardi F. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum Genet 1992; 89: 497-502.
26. Arbini AA, Mannucci PM, Bauer KA. A Thr359Mct mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 1996; 87: 5085-94.
27. Takamiya O, Kemball-Cook G, Martin DMA, Cooper DN, von Felten A, Meili E, Hann I, Prangnell DR, Lumley H, Tuddenham EGD, McVey JH. Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis in five dysfunctional variants of coagulation factor VII. Hum Mol Genet 1993; 2: 1355-9.
28. Chaing S, Clarke B, Sridhara S, Chu K, Friedman P, Van Dusen W, Roberts HR, Blajchman M, Monroe DM, High KA. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood 1994; 83: 3524-35.
29. Pinotti M, Toso R, Redaelli R, Berrettini M, Marchetti G, Bernardi F. Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene. Blood 1998; 92: 1646-51.
30. Peyvandi F, Mannucci PM, Jenkins PV, Perry DJ. Molecular characterisation of 22 families with factor VII deficiencies. Blood 1998; 92: Suppl. 1, Abstract 2922.
31. Wulff K, Herrmann FH. Molecular analysis of FVII gene in factor VII deficiency. Thromb Haemost 1999: Supplement: 139 (Abstract).
32. 2+-free GLA domain sheds light on membrane binding of blood coagulation proteins. Nature Struct Biol 1995; 2: 504-9.
33. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA 1996; 93: 14379-84.
34. Perkins SJ, Smith KF. Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures. Biochem J 1993; 295: 109-14.
35. McVey JH, Boswell EJ, Takamiya O, Tamagnini G, Valente V, Fidalgo T, Layton M, Tuddenham EGD. Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency. Blood 1998; 92: 920-6.
36. Tuddenham EGD, Pemberton S, Cooper DN. Inherited factor VII deficiency: genetics and molecular pathology. Thromh Haemost 1995; 74: 313-21.
37. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EGD. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132-40.
38. O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DM, Johnson DJ, Byfield PG, Takamiya O, Tuddenham EGD, McVey JH. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). Biochemistry 1994; 33: 14162-9.
39. Higashi S, Matsumoto N, Iwanaga S. Conformation of factor VIIa stabilized by a labile disulfide bond (Cys310-Cys329) in the protease domain is essential for interaction with tissue factor. J Biol Chem 1997; 272: 25724-30.